A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Brain Imaging Center - BIC
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Enrique Alvarez

Enrique Alvarez

Study ID

Protocol Number: 23-2271

More information available at ClinicalTrials.gov: NCT06141486

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers